| For: | Jiang QY, Xue RY. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: Markers predicting immune-checkpoint inhibitor efficacy and immune-related adverse events. World J Gastrointest Oncol 2024; 16(3): 577-582 [PMID: 38577447 DOI: 10.4251/wjgo.v16.i3.577] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i3/577.htm |
| Number | Citing Articles |
| 1 |
Kexin Zhang, Yi Ge, Yishi Xu, Chuhan Zhang, Liping Wang. Analysis of the efficacy and influencing factors of double-dose furmonertinib for advanced EGFR ex20ins non-small cell lung cancer. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07114-w
|
| 2 |
Shixin Ma, Fei Li, Lunqing Wang. The Construction of a Nomogram Using the Pan-Immune-Inflammation Value Combined with a PILE Score for Immunotherapy Prediction Prognosis in Advanced NSCLC. Cancer Management and Research 2024; : 741 doi: 10.2147/CMAR.S461964
|
